Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (5): 497-501.doi: 10.3736/jcim20070503
• Commentary • Previous Articles Next Articles
Hong-wei Zhang, Jian-ping Liu, Xia Wan, Yan-ke Ai
CLC Number:
[1] | Gray M, 唐金陵.循证医学-循证医疗卫生决策(第1版)[M]. 北京: 北京大学医学出版社, 2004,( 第1版):167-237 |
Gray M, Tang JL. Evidence-based decision making in health care(1st ed)[M]. Beijing: Peking University Medical Press, 2004,( 1st ed):167-237 | |
[2] |
郭新峰, 赖世隆, 梁伟雄 . 中医药临床疗效评价中结局指标的选择与应用[J]. 广州中医药大学学报, 2002,19(4):251-255
doi: 10.3969/j.issn.1007-3213.2002.04.002 |
Guo XF, Lai SL, Liang WX . Choice and application of the outcome indexes for clinical effectiveness assessment of traditional Chinese medicine[J]. Guangzhou Zhong Yi Yao Da Xue Xue Bao, 2002,19(4):251-255 | |
[3] | 谭燕, 刘鸣 . 抗高血压治疗二级预防国际大型临床试验的回顾[J]. 中国现代神经疾病杂志, 2005,5(6):377-380 |
Tan Y, Liu M . Review of large scale international clinical trials on secondary prevention of antihypertensive treatment[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2005,5(6):377-380 | |
[4] | 郭新峰, 朱泉, 赖世隆 . 替代指标和中间指标及其在中医药疗效评价研究中应用价值的思考[J]. 中国中西医结合杂志, 2005,25(7):585-590 |
Guo XF, Zhu Q, Lai SL . Thinking on surrogate outcomes, intermediary outcomes and their application in TCM clinical efficacy evaluation[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2005,25(7):585-590 | |
[5] | Ellenberg S, 刘淑红, 李海欣, 等.替代终点:一个值得讨论的热点问题[J]. 药物流行病学杂志, 2002,11(4):207-208 |
Ellenberg S, Liu SH, Li HX , et al. Surrogate endpoints: a hot topic worthy of more discussion[J]. Yao Wu Liu Xing Bing Xue Za Zhi, 2002,11(4):207-208 | |
[6] | 国家中医药管理局. 中华人民共和国中医药行业标准--中医病证诊断疗效标准(第1版)[M]. 南京: 南京大学出版社, 1994,( 第1版):6 |
State Administration of Traditional Chinese Medicine. Traditional Chinese medicine profession criterion for People's Republic of China--Standard for diagnosis and therapeutic effectiveness evaluation of traditional Chinese medicine syndromes(1st ed)[M]. Nanjing: Nanjing University Press, 1994,( 1st ed):6 | |
[7] | 赵利, 刘凤斌, 梁国辉 , 等. 中华生存质量量表的信度和效度[J]. 中国临床康复, 2006,10(8):1-3 |
Zhao L, Liu FB, Liang GH , et al. Reliability and validity of Chinese Quality of Life Instrument[J]. Zhongguo Lin Chuang Kang Fu, 2006,10(8):1-3 | |
[8] | 王家良 . 临床流行病学--临床科研设计、衡量与评价(第2版)[M]. 上海: 上海科学技术出版社, 2001,( 第2版):345-357 |
Wang JL . Clinical epidemiology--Clinical research design, measurement and evaluation(2nd ed)[M]. Shanghai: Shanghai Scientific and Techincal Publishers, 2001,( 2nd ed):345-357 | |
[9] | 刘建平 . 临床试验效应的表达--指标及其意义.[J] 中国中西医结合杂志, 2004,24(8):677-680 |
Liu JP . Effect measure of clinical trial--Item and significance[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2004,24(8):677-680 | |
[10] | Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. [2005-05][ 2005-05]. |
[11] | Moher D, Schultz KF, Altman D . The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials[J]. JAMA, 2001,285(15):1987-1991 |
[1] | Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394. |
[2] | Arthur Yin Fan, Hui Ouyang, Xinru Qian, Hui Wei, David Dehui Wang, Deguang He, Haihe Tian, Changzhen Gong, Amy Matecki, Sarah Faggert Alemi. Discussions on real-world acupuncture treatments for chronic low-back pain in older adults. Journal of Integrative Medicine, 2019, 17(2): 71-76. |
[3] | Shahnaz Karkon Varnosfaderani, Fataneh Hashem-Dabaghian, Gholamreza Amin, Mahbubeh Bozorgi, Ghazaleh Heydarirad, Esmaeil Nazem, Mohsen Nasiri Toosi, Seyed Hamdollah Mosavat. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: A double-blind, randomized, placebo-controlled clinical trial. Journal of Integrative Medicine, 2018, 16(2): 126-131. |
[4] | Fabiana de Almeida Andrade, Caio Fabio Schlechta Portella. Research methods in complementary and alternative medicine: An integrative review. Journal of Integrative Medicine, 2018, 16(1): 6-13. |
[5] | Steven H. Stumpf, Kory Ward-Cook, Clifford R. Carr. Comparing outcomes from the two most recognized acupuncturist workforce surveys. Journal of Integrative Medicine, 2017, 15(1): 37-43. |
[6] | Subhranil Saha, Munmun Koley, Subhasish Ganguly, Prasanta Rath, Pulak Roy Chowdhury, Seikh Intaj Hossain. Developing the criteria for evaluating quality of individualization in homeopathic clinical trialreporting: A preliminary study. Journal of Integrative Medicine, 2014, 12(1): 13-19. |
[7] | Feng-bin Liu, Zheng-kun Hou, Yun-ying Yang, Pei-wu Li, Qian-wen Li, Nelson Xie, Jing-wei Li, Xiang-jing Zeng. Literature review and analysis of the application of health outcome assessment instruments in Chinese medicine. Journal of Chinese Integrative Medicine, 2013, 11(3): 157-167. |
[8] | Feng-bin Liu, Zheng-kun Hou, Yun-ying Yang, Zheng-zheng Zhang, Di Xie, Nelson Xie, Hong Thach Nguyen. Literature review and analysis of the development of health outcomes assessment instruments in Chinese medicine. Journal of Chinese Integrative Medicine, 2013, 11(2): 80-89. |
[9] | Zhang-ling Zhou, Cheng-xin Li, Yue-bo Jiang, Cong Zuo, Yun Cai, Rui Wang. Correlation between facial nerve functional evaluation and efficacy evaluation of acupuncture treatment for Bell’s palsy. Journal of Chinese Integrative Medicine, 2012, 10(9): 997-1002. |
[10] | Jian-sheng Li, Ya Li, Su-yun Li, Yuan-yuan Wang, Li Deng, Yan-ge Tian, Su-li Jiang , Ying Wang. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease. Journal of Chinese Integrative Medicine, 2012, 10(9): 1039-1048. |
[11] | Zhao-lan Liu, Qing Li , Yu-jie Mu , Ying Gao, Jian-ping Liu. Using nested case-control study to appraise the effectiveness of Chinese medicines in the treatment of diabetic nephropathy. Journal of Chinese Integrative Medicine, 2012, 10(9): 991-996. |
[12] | Wei-hua Xu, Ze-huai Wen, Wei-xiong Liang, Qi Wang. A review of research on the development of instruments for therapeutic efficacy evaluation of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(7): 726-737. |
[13] | Christoph A. Doenitz, Ana Anjos, Thomas Efferth , Tobias Greten, Henry J. Greten. Can heat and cold be parameterized? Clinical data of a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(5): 532-537. |
[14] | Li-xin Ma, Yu-yi Wang, Xin-xue Li, Jian-ping Liu . Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(3): 279-292. |
[15] | Yan-bo Zhu , Hideki Origasa, Xiao-xia Luo, Yang-yang Wang , Jie Di , Lin Lin. Responsiveness of three subjective report of outcome measures for chronic heart failure. Journal of Chinese Integrative Medicine, 2012, 10(12): 1375-1381. |
|